Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
Maltais, François, Bjermer, Leif, Kerwin, Edward M, Jones, Paul W, Watkins, Michael L, Tombs, Lee, Naya, Ian P, Boucot, Isabelle H, Lipson, David A, Compton, Chris, Vahdati-Bolouri, Mitra, Vogelmeier, Claus F
Published in Respiratory research (30.10.2019)
Published in Respiratory research (30.10.2019)
Get full text
Journal Article
Long-term outcomes following first short-term clinically important deterioration in COPD
Naya, Ian P, Tombs, Lee, Muellerova, Hana, Compton, Christopher, Jones, Paul W
Published in Respiratory research (20.11.2018)
Published in Respiratory research (20.11.2018)
Get full text
Journal Article
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
Naya, Ian P., Tombs, Lee, Lipson, David A., Compton, Chris
Published in Advances in therapy (01.10.2018)
Published in Advances in therapy (01.10.2018)
Get full text
Journal Article
Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
Naya, Ian, Tombs, Lee, Lipson, David A, Boucot, Isabelle, Compton, Chris
Published in Respiratory research (26.03.2019)
Published in Respiratory research (26.03.2019)
Get full text
Journal Article
Measuring disease activity in COPD: is clinically important deterioration the answer?
Singh, Dave, Criner, Gerard J, Naya, Ian, Jones, Paul W, Tombs, Lee, Lipson, David A, Han, MeiLan K
Published in Respiratory research (02.06.2020)
Published in Respiratory research (02.06.2020)
Get full text
Journal Article
The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy
Buhl, Roland, Kuna, Piotr, Peters, Matthew J, Andersson, Tomas L G, Naya, Ian P, Peterson, Stefan, Rabe, Klaus F
Published in Respiratory research (20.07.2012)
Published in Respiratory research (20.07.2012)
Get full text
Journal Article
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
Maltais, François, Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Jones, Paul W., Boucot, Isabelle H., Lipson, David A., Tombs, Lee, Compton, Chris, Naya, Ian P.
Published in Respiratory medicine (01.08.2022)
Published in Respiratory medicine (01.08.2022)
Get full text
Journal Article
Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
Singh, Dave, Criner, Gerard J, Naya, Ian, Jones, Paul W, Tombs, Lee, Lipson, David A, Han, MeiLan K
Published in Respiratory research (20.11.2021)
Published in Respiratory research (20.11.2021)
Get full text
Journal Article
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Kerwin, Edward M, Jones, Paul W, Bjermer, Leif H, Maltais, François, Boucot, Isabelle H, Naya, Ian P, Lipson, David A, Compton, Chris, Tombs, Lee, Vogelmeier, Claus F
Published in Chronic Respiratory Disease (01.01.2023)
Published in Chronic Respiratory Disease (01.01.2023)
Get full text
Book Review
Journal Article
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Bjermer, Leif, Boucot, Isabelle H, Maltais, François, Kerwin, Edward M, Naya, Ian P, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Vogelmeier, Claus F
Published in International journal of chronic obstructive pulmonary disease (01.01.2021)
Published in International journal of chronic obstructive pulmonary disease (01.01.2021)
Get full text
Journal Article
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
Vogelmeier, Claus F, Naya, Ian P, Maltais, François, Bjermer, Leif, Kerwin, Edward M, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Boucot, Isabelle H
Published in International journal of chronic obstructive pulmonary disease (01.01.2021)
Published in International journal of chronic obstructive pulmonary disease (01.01.2021)
Get full text
Journal Article
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis
Han, MeiLan K, Criner, Gerard J, Dransfield, Mark T, Halpin, David M G, Jones, Christine E, Kilbride, Sally, Lange, Peter, Lettis, Sally, Lipson, David A, Lomas, David A, Martin, Neil, Martinez, Fernando J, Wise, Robert A, Naya, Ian P, Singh, Dave
Published in ERJ open research (01.01.2021)
Published in ERJ open research (01.01.2021)
Get full text
Journal Article
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, Maltais, François
Published in Therapeutic advances in respiratory disease (2020)
Published in Therapeutic advances in respiratory disease (2020)
Get full text
Journal Article
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol
Pavord, Ian D., DM, FRCP, Jeffery, Peter K., DSc (Med), Qiu, Yusheng, PhD, Zhu, Jie, PhD, Parker, Debbie, BSc, Carlsheimer, Åsa, BSc, Naya, Ian, BSc, Barnes, Neil C., FRCP
Published in Journal of allergy and clinical immunology (01.05.2009)
Published in Journal of allergy and clinical immunology (01.05.2009)
Get full text
Journal Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Maltais, Francois, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, Bjermer, Leif
Published in Therapeutic advances in respiratory disease (2020)
Published in Therapeutic advances in respiratory disease (2020)
Get full text
Journal Article
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Naya, Ian, Compton, Chris, Ismaila, Afisi S, Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A, Criner, Gerard
Published in ERJ open research (01.10.2018)
Published in ERJ open research (01.10.2018)
Get full text
Journal Article
Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
Shah, Dhvani, Driessen, Maurice, Risebrough, Nancy, Baker, Timothy, Naya, Ian, Briggs, Andrew, Ismaila, Afisi S
Published in Cost effectiveness and resource allocation (10.05.2018)
Published in Cost effectiveness and resource allocation (10.05.2018)
Get full text
Journal Article
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
CHRISTIAN VIRCHOW, J., Jr, PRASSE, ANTJE, NAYA, IAN, SUMMERTON, LINDA, HARRIS, ALLAN, The Zafirlukast Study Group
Published in American journal of respiratory and critical care medicine (01.08.2000)
Published in American journal of respiratory and critical care medicine (01.08.2000)
Get full text
Journal Article